Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

DSM announces final terms of Euro300 million bond

DSM

Royal DSM, the global Life Science and Material Sciences company, has adjusted the Final Terms of the 300,000,000 1.75% Notes due 13 November 2019 to correctly reflect that investors have a put option in the event of a change of control. The Final Terms can be found on the DSM website (http://www.dsm.com/corporate/investors/bonds-credit-rating/bonds-in-detail.html).

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

Or find us on:      

For more information:

DSM Corporate Communications

Herman Betten
tel. +31 (0) 45 5782017    
e-mail media.relations@dsm.com

DSM Investor Relations

Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.com



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire

HUG#1750938
Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today